The purpose of the IBD Registry is to improve care of patients and understanding of the treatments they receive, to enable research, and to increase knowledge about IBD in the UK.

We do this by collecting and analysing data from IBD patients nationally. With over 54,000 records, we are one of the largest IBD registries in Europe.

The Registry will shortly publish its first Annual Report on the Use of Biologics for Inflammatory Bowel Diseases.  It will be published on this website; however if you would like to be sent a copy when it is published please email [email protected]

IBD Registry key partner in the new HDR funded data research hub for IBD research click here for more information

We are a new not-for-profit company…

… owned by three member organisations: the Royal College of Physicians, The British Society of Gastroenterology, and Crohn’s & Colitis UK.  Find out more about us here.

Our growing dataset has the potential to enable new research into IBD and also to inform clinical commissioning decisions.

We work with over 100 hospitals across the UK to gather in defined IBD data on an ongoing (longitudinal) basis.

We are the appointed Quality Accounts provider for IBD by NHS England, enabling the measured improvements in standards of care and treatment.

We use our national hospital data network to support new research projects and also to enable monitoring of the safety of certain new biologic drugs.

Important information for Registry-participating clinical teams: the next data submission deadline is Friday 4th October although data can be submitted before this date.  The deadlines for the next year (all Fridays) are: 4th October 2019; 10th January 2020; 3rd April 2020; 10th July 2020; 9th October 2020.

Unlocking value through linking health datasets

The assurance of our data safeguarding process has meant that we have been able to link our dataset to other NHS datasets, especially the Hospital Episodes Statistics (HES) dataset.

This has enabled our data analytics team to produce new insights, on a per hospital basis, from combining our wide knowledgebase of IBD with the focused data of the emergency admissions dataset.

Dr Keith Bodger, Academic Lead for the Registry, talks about the benefits of linking Registry data to other datasets

The shift to patient data

Health data is in very much in the spotlight with its potential to underpin real change in the way health services are delivered.

The Registry is already looking ahead to the future with its ambition to incorporate and build around patient-reported outcomes and patient-entered data.  We believe that the rise of patient data will mark a shift in both care and process for patients and the clinical teams that support them.

Included in our current activities is a project to allow patient apps (on smartphones and tablets) to integrate securely and with appropriate safeguards maintained into the Registry.

Dr Stuart Bloom, Medical Director for the Registry, talks about the future with patient-entered data.

The yardstick for quality

The Registry collects data on an ongoing basis from clinical teams nationwide and so is in a unique position to be able to provide regular ongoing measures that reflect quality of care and service within hospitals.

Building on our track record in Quality Accounts and our heritage from the RCP’s Clinical Audit programme we are now pleased to be working in close partnership with IBD Standards 2019 and the BSG IBD QI programme to underpin their work with our tracking and measuring capability.  What gets measured, gets done.

IBD Registry Ltd is a not-for-profit company limited by guarantee - Company Number 11197749.
Our Registered Address is 3 St Andrews Place, Regent’s Park, London NW1 4LB. VAT Number 291683766.